变应性鼻炎舌下免疫治疗不依从的真实世界分析
该研究回顾性分析2009年12月至2015年2月启动舌下免疫治疗的142例变应性鼻炎患者,在治疗1、3、6、12个月时按常规进行电话随访并询问停药原因。结果76例(54%)在治疗第一年内终止免疫治疗,停药原因包括无法联系(25%)、无效(24%)、疗程长(18%)、症状改善(13%)、副作用(4%)、对治疗缺乏信心(4%)及其他原因(12%)。
要点
- 142例变应性鼻炎患者中76例(54%)在舌下免疫治疗第一年内终止治疗。
- 停药原因前三位为无法联系(25%)、无效(24%)和疗程长(18%)。
- 症状改善(13%)、副作用(4%)和对治疗缺乏信心(4%)也是停药原因。
核心结论
- 54%的变应性鼻炎患者在舌下免疫治疗第一年内终止治疗。
- 终止治疗的主要原因包括无法联系、无效和疗程长。
研究设计与样本
- 回顾性分析2009年12月至2015年2月启动舌下免疫治疗的142例变应性鼻炎患者。
- 在治疗1、3、6、12个月时按常规进行电话随访,询问自称已停止治疗者的原因。
主要发现
- 76例(54%)患者在治疗第一年内终止免疫治疗。
- 停药原因:无法联系25%、无效24%、疗程长18%、症状改善13%、副作用4%、对治疗缺乏信心4%、其他原因12%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To sustain the long-lasting beneficial effects of allergen-specific sublingual immunotherapy (SLIT), an adequate duration of treatment is required. Nevertheless, many patients discontinue prematurely and therefore fail to obtain satisfactory therapeutic effect in clinical practice. The aim of this study was to analyze the causes leading to premature discontinuation of SLIT in allergic rhinitis (AR), and to provide the corresponding countermeasures for the following SLIT course. METHODS: We performed a retrospective analysis of data from 142 patients with AR who started SLIT during the period from December 2009 to February 2015. Patients were contacted at 1, 3, 6, and 12 months into SLIT as part of our standard of care. The patients who claimed to have stopped treatment were asked to provide a reason during one of the phone calls. RESULTS: Overall, 76 (54%) patients with AR terminated immunotherapy during the first year of treatment. Among the 76 patients, the following reasons were cited for nonadherence to immunotherapy: patients could not be reached (25%); ineffectiveness (24%); the long course (18%); improvement of symptoms (13%); side effects (4%); lack of confidence in the treatment (4%); or other reasons (12%). CONCLUSION: Fifty-four percent of AR patients terminated their treatment within the first year of SLIT. The top reasons for treatment discontinuation included patients not be reached, ineffectiveness, and length of course.
引用
- Wang T, Li Y, Wang F, et al. Nonadherence to sublingual immunotherapy in allergic rhinitis: a real-life analysis. Int Forum Allergy Rhinol. 2017. PMID: 28151587. doi:10.1002/alr.21909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。